Use of 5-Alpha-Reductase Inhibitors Did Not Increase the Risk of Cardiovascular Diseases in Patients with Benign Prostate Hyperplasia: A Five-Year Follow-Up Study

BACKGROUND: This nationwide population-based study investigated the risk of cardiovascular diseases after 5-alpha-reductase inhibitor therapy for benign prostate hyperplasia (BPH) using the National Health Insurance Research Database (NHIRD) in Taiwan. METHODS: In total, 1,486 adult patients newly d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Teng-Fu, Yang, Yu-Wan, Lee, Shang-Sen, Lin, Tien-Huang, Liu, Hsin-Ho, Tsai, Tsung-Hsun, Chen, Chi-Cheng, Huang, Yung-Sung, Lee, Ching-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372445/
https://www.ncbi.nlm.nih.gov/pubmed/25803433
http://dx.doi.org/10.1371/journal.pone.0119694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372445/
https://www.ncbi.nlm.nih.gov/pubmed/25803433
http://dx.doi.org/10.1371/journal.pone.0119694

Ejemplares similares